1. Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction
by Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín, Ferran Torres, M. Dolores Jiménez, Aida Lago, and Teresa Melo
Stroke
Volume 34(4):
April 1, 2003
Copyright © American Heart Association, Inc. All rights reserved.

2. Figure 1. Trial profile.
Figure 1. Trial profile. ITT indicates intention to treat; PP, per protocol.
Jordi Matías-Guiu et al. Stroke. 2003;34:
Copyright © American Heart Association, Inc. All rights reserved.

3. Figure 2. Survival analysis of primary end point (nonfatal ischemic stroke, nonfatal AMI, vascular death).
Figure 2. Survival analysis of primary end point (nonfatal ischemic stroke, nonfatal AMI, vascular death).
Jordi Matías-Guiu et al. Stroke. 2003;34:
Copyright © American Heart Association, Inc. All rights reserved.

4. Figure 3. Cumulative risk of any cerebral or major systemic hemorrhages.
Jordi Matías-Guiu et al. Stroke. 2003;34:
Copyright © American Heart Association, Inc. All rights reserved.